University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol
NCT01463475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2014-12-04
Summary
The objective of this protocol is to use established standard criteria and methods for the collection of hMSC (human mesenchymal stromal cells) from healthy bone marrow donors. The hMSC collected from the donors will use to develop well-defined and reproducible cell banks. Standard manufacturing procedures and quality control testing methods will be used to characterize and evaluate the final cell product. After the cell banks are created, these cell products will be used in future translational or clinical research.
Conditions
- Graft Versus Host Disease (GVHD)
- Acute Myocardial Infarction (AMI)
Interventions
- PROCEDURE
-
Bone marrow aspirate
A single bone marrow aspirate procedure is planned.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Peiman Hematti, MD · University of Wisconsin, Madison
-
John M Centanni, MS · University of Wisconsin, Madison
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies
NCT02804945 ·Status: COMPLETED ·Phase: PHASE1
-
Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
NCT04345601 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial Infarctions
NCT00264316 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial With MSC for Graft Versus Host Disease Treatment
NCT02687646 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
NCT04565665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome
NCT01775774 ·Status: COMPLETED ·Phase: PHASE1
-
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
NCT02032446 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome
NCT03818854 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure
NCT00721045 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)
NCT01770613 ·Status: WITHDRAWN ·Phase: PHASE2
-
Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease
NCT01765634 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction
NCT00114452 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction
NCT03533153 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Bone Marrow Stem Cell Infusion Following a Heart Attack
NCT00268307 ·Status: COMPLETED ·Phase: PHASE1
-
Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)
NCT02097641 ·Status: COMPLETED ·Phase: PHASE2
-
Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn
NCT03967275 ·Status: COMPLETED
-
Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration
NCT00224536 ·Status: COMPLETED ·Phase: PHASE1
-
MSC Therapy in Liver Transplantation
NCT02260375 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure
NCT02467387 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
NCT04780685 ·Status: UNKNOWN ·Phase: PHASE2
-
Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
NCT02336646 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles
NCT05520125 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Ophthalmology Treatment Study
NCT01920867 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction
NCT01392105 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
NCT00260338 ·Status: COMPLETED ·Phase: PHASE1/PHASE2